Scientists scan brains to see if new drug boosts memory in schizophrenia
NCT ID NCT04457310
Summary
This study aimed to understand how an experimental drug called CVL-562 affects brain circuits involved in memory for people with early schizophrenia. Researchers gave 112 participants different doses of the drug and used MRI brain scans to measure activity while they performed memory tasks. The goal was to find biological markers to help develop better treatments for the thinking problems common in schizophrenia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY COURSE SCHIZOPHRENIA SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University
New York, New York, 10032, United States
-
Stony Brook University
Stony Brook, New York, 11794, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Yale University
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.